Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

1.5K
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.5K
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

7.1K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
7.1K
Analgesia and Pain Management01:25

Analgesia and Pain Management

3.2K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
3.2K
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

1.7K
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
1.7K
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

1.6K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.6K
Drug Dependence01:17

Drug Dependence

2.0K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mu Opioid Receptor mRNA and Protein Localization Across the Rat and Mouse Habenula.

The Journal of comparative neurology·2026
Same author

Mu opioid receptor mRNA and protein localization across the rat and mouse habenula.

bioRxiv : the preprint server for biology·2025
Same author

Lost in translation: past, present, and future of pain research.

Pain·2025
Same author

A switch in kappa opioid receptor signaling from inhibitory to excitatory induced by stress in a subset of cortically-projecting dopamine neurons.

bioRxiv : the preprint server for biology·2025
Same author

Structure-guided design of partial agonists at an opioid receptor.

Nature communications·2025
Same author

Ketamine and Major Ketamine Metabolites Function as Allosteric Modulators of Opioid Receptors.

Molecular pharmacology·2024
Same journal

Exercise as a regulator of glymphatic function.

Trends in neurosciences·2026
Same journal

The neural basis of laughter.

Trends in neurosciences·2026
Same journal

Enteric neuroimmune interactions in health and disease.

Trends in neurosciences·2026
Same journal

Atomic insights into the physiological and functional diversity of NMDA receptors.

Trends in neurosciences·2026
Same journal

Cognitive functions of the GPe.

Trends in neurosciences·2026
Same journal

Re-examining the structure-function relationship in tactile corpuscles.

Trends in neurosciences·2026
See all related articles

Related Experiment Video

Updated: Apr 18, 2026

A Conflict Model of Reward-seeking Behavior in Male Rats
06:11

A Conflict Model of Reward-seeking Behavior in Male Rats

Published on: February 20, 2019

8.0K

Understanding opioid reward.

Howard L Fields1, Elyssa B Margolis1

  • 1Department of Neurology, The Wheeler Center for the Neurobiology of Addiction, Alcoholism and Addiction Research Group, University of California, San Francisco, CA, USA.

Trends in Neurosciences
|February 2, 2015
PubMed
Summary
This summary is machine-generated.

Scientists are exploring how to harness the pain-relieving power of opioids while minimizing addiction. Research focuses on the mu opioid (MOP) receptor in the brain

Keywords:
VTAaddictionmidbrainmorphinemu opioid receptor

More Related Videos

A Conditioned Place Preference Protocol for Measuring Incubation of Craving in Rats
04:11

A Conditioned Place Preference Protocol for Measuring Incubation of Craving in Rats

Published on: November 6, 2018

18.0K
A Procedure to Study Stress-Induced Relapse of Heroin Seeking after Punishment-Imposed Abstinence
08:05

A Procedure to Study Stress-Induced Relapse of Heroin Seeking after Punishment-Imposed Abstinence

Published on: March 23, 2022

3.2K

Related Experiment Videos

Last Updated: Apr 18, 2026

A Conflict Model of Reward-seeking Behavior in Male Rats
06:11

A Conflict Model of Reward-seeking Behavior in Male Rats

Published on: February 20, 2019

8.0K
A Conditioned Place Preference Protocol for Measuring Incubation of Craving in Rats
04:11

A Conditioned Place Preference Protocol for Measuring Incubation of Craving in Rats

Published on: November 6, 2018

18.0K
A Procedure to Study Stress-Induced Relapse of Heroin Seeking after Punishment-Imposed Abstinence
08:05

A Procedure to Study Stress-Induced Relapse of Heroin Seeking after Punishment-Imposed Abstinence

Published on: March 23, 2022

3.2K

Area of Science:

  • Neuroscience
  • Pharmacology
  • Addiction Research

Background:

  • Opioids are potent analgesics but carry a high risk of addiction due to their rewarding properties.
  • The mu opioid (MOP) receptor is central to both opioid analgesia and reward.
  • The ventral tegmental area (VTA) dopaminergic neurons, crucial for reward processing, are key targets for opioid action.

Purpose of the Study:

  • To investigate how MOP receptor activity in VTA neuron subsets contributes to opioid reward.
  • To understand how behavioral states influence MOP receptor agonist effects on VTA circuits.

Main Methods:

  • Examined MOP receptor function in VTA dopaminergic neurons.
  • Investigated the role of VTA circuits in opioid reward.
  • Manipulated animal behavioral states (e.g., food deprivation, prior agonist exposure) to assess effects on MOP receptor activity.

Main Results:

  • Opioid reward is dependent on MOP receptor function within the VTA.
  • Specific VTA neuron subsets exhibit distinct pharmacological properties and circuit involvement.
  • Behavioral state significantly modulates the impact of MOP receptor agonists on VTA circuits.

Conclusions:

  • Understanding VTA circuit heterogeneity is crucial for developing safer analgesics.
  • Targeting MOP receptors within specific VTA circuits may offer a strategy to separate analgesia from reward.
  • Behavioral state-dependent modulation of MOP receptor signaling presents a complex factor in opioid action.